BIO-Key International Inc (BKYI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BIO-Key International Inc (BKYI) has a cash flow conversion efficiency ratio of -0.238x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.82 Million) by net assets ($7.67 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BIO-Key International Inc balance sheet independence to measure how much of total assets are equity-financed.
BIO-Key International Inc - Cash Flow Conversion Efficiency Trend (1996–2025)
This chart illustrates how BIO-Key International Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BIO-Key International Inc (BKYI) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
BIO-Key International Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BIO-Key International Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Foresight Solar Fund Ltd
LSE:FSFL
|
0.015x |
|
Porvair plc
LSE:PRV
|
0.095x |
|
IMMO BLOCKCHAIN EO 1
F:QT5
|
N/A |
|
SATO Technologies Corp
V:SATO
|
-0.336x |
|
Macarthur Minerals Ltd
AU:MIO
|
-0.005x |
|
Treasure Global Inc.
NASDAQ:TGL
|
-0.147x |
|
Golden Tobacco Limited
NSE:GOLDENTOBC
|
0.032x |
|
Manugraph India Limited
NSE:MANUGRAPH
|
0.053x |
Annual Cash Flow Conversion Efficiency for BIO-Key International Inc (1996–2025)
The table below shows the annual cash flow conversion efficiency of BIO-Key International Inc from 1996 to 2025. For the full company profile with market capitalisation and key ratios, see BKYI market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $7.67 Million | $-4.66 Million | -0.608x | +21.29% |
| 2024-12-31 | $3.77 Million | $-2.91 Million | -0.773x | +78.34% |
| 2023-12-31 | $1.06 Million | $-3.79 Million | -3.567x | -203.57% |
| 2022-12-31 | $5.30 Million | $-6.23 Million | -1.175x | -104.35% |
| 2021-12-31 | $15.62 Million | $-8.98 Million | -0.575x | -136.20% |
| 2020-12-31 | $20.34 Million | $-4.95 Million | -0.243x | -130.06% |
| 2019-12-31 | $-2.29 Million | $-1.85 Million | 0.810x | +625.24% |
| 2018-12-31 | $10.47 Million | $-1.61 Million | -0.154x | +14.00% |
| 2017-12-31 | $13.75 Million | $-2.47 Million | -0.179x | +37.71% |
| 2016-12-31 | $15.45 Million | $-4.45 Million | -0.288x | +66.43% |
| 2015-12-31 | $18.15 Million | $-15.56 Million | -0.857x | +74.00% |
| 2014-12-31 | $759.06K | $-2.50 Million | -3.297x | -29.12% |
| 2013-12-31 | $1.05 Million | $-2.68 Million | -2.554x | -4645.12% |
| 2012-12-31 | $-1.22 Million | $65.55K | -0.054x | -113.08% |
| 2011-12-31 | $-1.27 Million | $-523.11K | 0.412x | +174.88% |
| 2010-12-31 | $569.34K | $-312.93K | -0.550x | +63.19% |
| 2009-12-31 | $1.11 Million | $-1.65 Million | -1.493x | -3462.43% |
| 2008-12-31 | $-3.08 Million | $129.17K | -0.042x | -105.37% |
| 2007-12-31 | $-2.77 Million | $-2.16 Million | 0.781x | -39.67% |
| 2006-12-31 | $-2.74 Million | $-3.55 Million | 1.295x | +366.96% |
| 2005-12-31 | $9.31 Million | $-4.51 Million | -0.485x | +8.76% |
| 2004-12-31 | $10.62 Million | $-5.64 Million | -0.531x | -269.94% |
| 2003-12-31 | $-9.14 Million | $-2.86 Million | 0.313x | -0.90% |
| 2002-12-31 | $-7.18 Million | $-2.26 Million | 0.316x | -36.14% |
| 2001-12-31 | $-3.90 Million | $-1.93 Million | 0.494x | -5.77% |
| 2000-12-31 | $-3.29 Million | $-1.72 Million | 0.524x | -59.86% |
| 1999-12-31 | $-1.68 Million | $-2.20 Million | 1.307x | -84.04% |
| 1998-12-31 | $-556.61K | $-4.56 Million | 8.187x | +1223.68% |
| 1997-12-31 | $3.64 Million | $-2.65 Million | -0.729x | -116.65% |
| 1996-12-31 | $-156.17K | $-683.59K | 4.377x | -- |
About BIO-Key International Inc
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education sectors in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity … Read more